The transplant programs at Baylor University Medical Center, part of Baylor Scott & White Health and Baylor Scott & White All Saints Medical Center – Fort Worth, together have performed more than 4300 kidney transplants since the kidney transplant program began in 1985. In the past decade, we’ve averaged 200 kidney transplants annually at the Baylor transplant programs. 

At the Annette C. and Harold C. Simmons Transplant Institute, kidney transplant candidates also have the option of considering a combined kidney/pancreas transplant. Simultaneous kidney-pancreas transplants are performed for patients with either Type 1 or Type 2 diabetes who qualify. The dual transplant functions better than a kidney alone because the new pancreas protects the transplanted kidney from the harmful effects of diabetes. As a result, the new kidney performs better and longer in the kidney/pancreas transplant recipient. Many kidney/pancreas transplant recipients are free of diabetes years after their transplant and report a better quality of life than kidney-alone patients.

Patients on the waitlists at Baylor will wait on average four months for a simultaneous kidney/pancreas transplant. This reflects some of the shortest wait times of all transplant centers in the region and nation.

Kidney transplant candidates and kidney/pancreas transplant candidates gain improved access to organs through Annette C. and Harold C. Simmons Transplant Institute’s two transplant center locations at Baylor University Medical Center and Baylor Scott & White All Saints Medical Center – Fort Worth. These two transplant center locations are served by two separate organ procurement organizations (OPO) providing patients access to organs from both OPOs.

Our elite group of surgeons at Transplant Services collaborates with Annette C. and Harold C. Simmons Transplant Institute to perform comprehensive kidney and pancreas transplantations. The Institute oversees and guides the transplant programs at Baylor University Medical Center, part of Baylor Scott & White Health and Baylor All Saints Medical Center Fort Worth.

Through Transplant Services and Annette C. and Harold C. Simmons Transplant Institute, patients receive complete kidney and pancreas transplantation services, including evaluations, living kidney donation coordination, transplant surgery, post-operative care, long-term follow-up care, support groups, housing coordination and financial services.

Since the program's inception, Baylor University Medical Center has performed more than 2,900 kidney or combined kidney/pancreas transplants. This volume positions Baylor University Medical Center as one of the largest kidney transplant programs in Texas.

We are the first center in Texas to gain FDA permission to process pancreatic islet cells for transplantation, and we're the first hospital in the Southwest to perform islet cell transplantation from our own lab for Type 1 diabetes patients and chronic pancreatitis patients. Baylor is one of the few medical centers in the world to offer this procedure.

Auto islet cells transplantation is an innovative treatment for carefully selected patients in pain from chronic pancreatitis. After undergoing complete removal of the pancreas​ and spleen, patients receive a transplant from their own islets, which include the cells that produce insulin.

Patients who have undergone islet cell transplant have been able to achieve much or all of the pain they experienced with chronic pancreatitis and through the injection of islet cells, have avoided the diagnosis of diabetes. At Baylor, we actively perform islet cell transplants, in an effort to achieve across-the-board blood sugar control improvement.

Baylor University Medical Center is the first transplant program in the world to offer uterus transplants outside of a clinical trial. We have the only program in the United States to deliver babies using uteri from both living and deceased donors and the first uterus transplant program in the nation to successfully deliver two babies from one transplanted uterus.

Our program’s success is attributed to a multidisciplinary team of specialists in transplant, gynecology, obstetrics and maternal/fetal medicine who have remained committed to advancing the science of uterus transplantation for the benefit of the broader medical community and women with uterine factor infertility